Keywords
HIV
Directly observed therapy
Antiretroviral therapy
Coinfection
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the prevalence of tuberculosis (TB) treatment abandonment among patients co-infected with HIV, reported in the metropolitan region of Belém - PA. Methods: This is an epidemiological, retrospective, and descriptive study with a quantitative approach, with secondary data collected from the Department of Information Technology of the Unified Health System (DATASUS). Results: Between 2017 and 2021, 1,628 cases of co-infection (TB-HIV) were registered. Most cases occurred in the city of Belém (79%), in men (73%), aged between 20 and 39 years (56.7%) and with low education (35.8%). A total of 289 occurrences of treatment abandonment were recorded during this period. Conclusion: Cases of TB/HIV co-infection occurred predominantly in Belém, in men aged 20 to 39 years, with incomplete elementary education, and presented a high frequency of treatment abandonment. This study highlighted the effectiveness of Directly Observed Treatment (DOT) in mitigating abandonment and identified the concomitant use of Antiretroviral Therapy (ART) as a factor associated with treatment abandonment, thus supporting the formulation of public policies that promote treatment adherence.
References
ABBARA A, et al. Time to diagnosis of tuberculosis is greater in older patients: a retrospective cohort review. ERJ open research, 2019; 5(4).
ALVES ACS, SOUTO RCF. Casos de coinfecção por tuberculose e HIV no estado de Goiás, no período de 2008 a 2019. Revista Brasileira Militar de Ciências, 2021; 7(17).
ARROYO LH, et al. Modelo preditivo dos resultados desfavoráveis da tuberculose multidroga-resistente. Revista de Saúde Pública, 2021; 53(77).
BALUKU JB, et al. Gender differences among patients with drug resistant tuberculosis and HIV co-infection in Uganda: a countrywide retrospective cohort study. BMC infectious diseases, 2021; 21: 1-11.
CDC. Centers for Disease Control and Prevention. 2019. Reported Tuberculosis in the United States, 2019. Disponível em: https://archive.cdc.gov/www_cdc_gov/tb/statistics/reports/2019/risk_factors.htm. Acesso em nov. 2022
CHEADE MFM, et al. Caracterização da tuberculose em portadores de HIV/AIDS em um serviço de referência de Mato Grosso do Sul. Revista da Sociedade Brasileira de Medicina Tropical, 2009; 42: 119-125.
DALBO M, TAMISO A. Incidence and predictors of tuberculosis among HIV/AIDS infected patients: a five-year retrospective follow-up study. Advances in Infectious Diseases, 2016; 6(2): 70.
DAL’NEGRO SH. Impacto da pandemia da COVID-19 no rastreamento e diagnóstico do câncer do colo do útero no Brasil. Trabalho de Conclusão de Curso (Bacharel em Medicina) - Universidade Federal do Paraná, 2022.
DE MIRANDA LO, et al. Aspectos epidemiológicos da coinfecção Tuberculose/HIV no Brasil: revisão integrativa. Revista Prevenção de Infecção e Saúde, 2017; 3(3).
DIBBERN J, et al. Sex differences in the C57BL/6 model of Mycobacterium tuberculosis infection. Scientific reports, 2017; 7(1): 10957.
FAPESPA. Fundação Amazônia de Amparo a Estudos e Pesquisas. Anuário Estatístico do Pará 2020. Disponível em: https://www.fapespa.pa.gov.br/sistemas/anuario2020/tabelas/demografia/tab-1.1-populacao-total-e-estimativas-populacionais-2016-a-2020.htm. Acesso em janeiro de 2025.
GAMTESA DF, et al. Health care seeking behavior among presumptive tuberculosis patients in Ethiopia: a systematic review and meta-analysis. BMC Health Serv Res, 2020; 20(1): 445.
GIOSEFFI JR, et al. Tuberculose, vulnerabilidades e HIV em pessoas em situação de rua: revisão sistemática. Revista de Saúde Pública, 2022; 56: 43.
HERTZ D, SCHNEIDER B. Sex differences in tuberculosis. In: Seminars in immunopathology. Springer Berlin Heidelberg, 2019: 225-237.
LÍRIO M, et al. Completeness of tuberculosis reporting forms for disease control in individuals with HIV/AIDS in priority cities of Bahia state. Ciência & Saúde Coletiva, 2015; 20: 1143-1148.
MAGNO ES, et al. Fatores associados à coinfecção tuberculose e HIV: o que apontam os dados de notificação do Estado do Amazonas, Brasil, 2001-2012. Cadernos de Saúde Pública, 2017; 33: e00019315
MEY A, et al. Motivations and barriers to treatment uptake and adherence among people living with HIV in Australia: a mixed-methods systematic review. AIDS Behav, 2017; 21(2): 352–85.
MKELE G. The role of the pharmacist in TB management. SA Pharmaceutical Journal, 2010; 77(2): 18-20.
MOREIRA G, et al. ANÁLISE EPIDEMIOLÓGICA DA TUBERCULOSE NO CEARÁ: PERÍODO DE 2012 A 2023. Brazilian Journal of Implantology and Health Sciences, 2024; 6(8): 2910-2923.
OMS. Organização Mundial da Saúde. 2021. Relatório Global sobre Tuberculose 2021. Disponível em: https://iris.who.int/bitstream/handle/10665/346387/9789240037021-eng.pdf. Acesso em junho de 2022.
SILVA JAG, et al. Fatores associados à não adesão aos antirretrovirais em adultos com AIDS nos seis primeiros meses da terapia em Salvador, Bahia, Brasil. Cad. Saúde Pública, Rio de Janeiro, 2019; 31(6): 1188-1198.
SOUZA SS, SILVA DMGV. Passando pela experiência do tratamento para tuberculose. Texto & Contexto-Enfermagem, 2010; 19: 636-643.
SULLIVAN J, WOLLA SA. Education, income, and wealth. Page One Economics Newsletter, 2017: 1.